8 Matching Annotations
  1. Last 7 days
  2. 52.53.155.43 52.53.155.43
    1-s2.0-S2950329925001316-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/726d5e6775ea08a0ad2c07d3669773572ba926a8/1-s2.0-S2950329925001316-main-html.html
  3. Jul 2024
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11247952/
  5. Dec 2023
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase 1b Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10722139/
  7. 52.53.155.43 52.53.155.43
    ccr-23-0229-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/ff14fa8c7ad9abea8294fa337473afc457723345/ccr-23-0229-html.html
  8. Oct 2022
  9. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct biomarker profiles and TCR sequence diversity characterize the response to PD-L1 blockade in a mouse melanoma model
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9533714/
  10. Sep 2021
  11. www.sciencedirect.com www.sciencedirect.com
    Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821004487
  12. Aug 2021
  13. www.sciencedirect.com www.sciencedirect.com
    Untitled document
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124718317558
  14. Oct 2020
  15. pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
    CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubmed.ncbi.nlm.nih.gov/33205076/